Submit Deal

Submit Deal

Cover Image Iris Wang

Iris Wang

Managing Director of Asia-Pacific at ORBIMED ADVISORS LLC

Investor

Deal Bio

Total Deals2

Valued Deals2

Total Value£ 248 M

Avg. Deal Size£ 124 M

Market Context

Sort

24 Feb 2021|China|Biotechnology

Target: YISHENG BIOPHARMA

Bidder: ADJUVANT CAPITAL

16 Service Providers

4 Target | 12 Bidder

12 Dealmakers

2 Target | 10 Bidder

£ 92 M

Value

08 Jun 2021|China|Health Care Services

Target: DINGDANG HEALTH

Bidder: TPG CAPITAL ASIA

7 Service Providers

1 Target | 6 Bidder

7 Dealmakers

1 Target | 6 Bidder

£ 155 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite